search
Back to results

MEOPA to Improve Physical Therapy Results After Multilevel Surgery (KINOPA)

Primary Purpose

Cerebral Palsy, Spastic Diplegia, Quadriplegia

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
MEOPA
Medicinal air
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cerebral Palsy focused on measuring MEOPA, spasticity, multilevel surgery, cerebral palsy, children

Eligibility Criteria

6 Years - 20 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Multilevel surgery
  • Spastic cerebral palsy

Exclusion Criteria:

  • Patient not being able to walk

Sites / Locations

  • Robert Debré University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

1

2

Arm Description

Administration of MEOPA gaz during postoperative physical therapy

Administration of medical air during postoperative physical therapy

Outcomes

Primary Outcome Measures

Knee range of motion

Secondary Outcome Measures

Improvement of function after surgery

Full Information

First Posted
February 28, 2008
Last Updated
February 2, 2023
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00632528
Brief Title
MEOPA to Improve Physical Therapy Results After Multilevel Surgery
Acronym
KINOPA
Official Title
Evaluation of the Efficacy of "MEOPA" Used to Obtain Better ROM Immediately After Multilevel Surgery in Children With Spastic Diplegia, Quadriplegia or Hemiplegia.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2008
Overall Recruitment Status
Completed
Study Start Date
March 2008 (undefined)
Primary Completion Date
March 2011 (Actual)
Study Completion Date
March 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Children with cerebral palsy commonly undergo "multilevel surgery", meaning several lower limb combined procedures performed during the same surgical intervention. The aim of this type of surgery is to correct all deformities together in order to restore near to normal anatomy and muscular function. It is very important to be able to obtain good range of motion after surgery, in order to consolidate surgical results. During the first days after the operation, children are sore and it may be difficult to realize adequate physical therapy. In order to palliate this situation, MEOPA gaz is used during REHAB sessions. Good results have been obtained so far but no study is available to demonstrate these results. The goal of our research is to prove that there is a benefit in using MEOPA postoperatively in these patients.
Detailed Description
The study is a randomized, single blinded, controlled clinical trial. It consist of two groups of patients: one group will receive MEOPA (FDA approval-"AMM" in France, 2003) and the other will receive medical air. Results, in terms of articular range of motion, will be compared between groups after five sessions of REHAB. The following items will be evaluated: degree of pain, measured by a pain scale; joint ROM; number of sessions to obtain the desired results; parents, patients and caregivers satisfaction. Patients aging from 6 to 20 years will be included if they meet selection criteria. Inclusions are confirmed before the first session starts. At this time, informed consent is to be signed by patients or parents and the Clinical Epidemiology Unit will assign a study number to the patient. All patients get morphine therapy before the REHAB session; a new dose is administrated 10 minutes later if pain is higher than 4/10; ten minutes later, if pain is still over 4/10, MEOPA (or medical air) will be administrated. If this is not enough to diminish pain, the session will be interrupted. Five physical therapy sessions are provided after surgery, during inpatient time. Knee ROM will be measured by goniometry and will be the measure of reference to evaluate the influence of MEOPA. Two types of pain scale will be used: analogical scale from 1 to 10 and faces scale (FPS-R) for small children. For security reasons, the person who administrates de gaz will be informed of the nature of the product (MEOPA or medical air), the bottle will be masked and the therapist won't know what kind of product is being administrated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cerebral Palsy, Spastic Diplegia, Quadriplegia, Hemiplegia
Keywords
MEOPA, spasticity, multilevel surgery, cerebral palsy, children

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
64 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Administration of MEOPA gaz during postoperative physical therapy
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
Administration of medical air during postoperative physical therapy
Intervention Type
Drug
Intervention Name(s)
MEOPA
Intervention Description
Administration of MEOPA gaz during postoperative physical therapy
Intervention Type
Drug
Intervention Name(s)
Medicinal air
Intervention Description
Administration of medical air during postoperative physical therapy
Primary Outcome Measure Information:
Title
Knee range of motion
Time Frame
at 7 days
Secondary Outcome Measure Information:
Title
Improvement of function after surgery
Time Frame
at 7 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Multilevel surgery Spastic cerebral palsy Exclusion Criteria: Patient not being able to walk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ana PRESEDO, MD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Robert Debré University Hospital
City
Paris
ZIP/Postal Code
75019
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
28726270
Citation
Delafontaine A, Presedo A, Mohamed D, Lopes D, Wood C, Alberti C. Equimolar mixture of nitroux oxyde and oxygen during post-operative physiotherapy in patients with cerebral palsy: A randomized, double-blind, placebo-controlled study. Eur J Pain. 2017 Nov;21(10):1657-1667. doi: 10.1002/ejp.1071. Epub 2017 Jul 20.
Results Reference
result

Learn more about this trial

MEOPA to Improve Physical Therapy Results After Multilevel Surgery

We'll reach out to this number within 24 hrs